Previous Page  247 / 490 Next Page
Information
Show Menu
Previous Page 247 / 490 Next Page
Page Background

245

POSTERS AND ELECTRONIC POSTERS

| PROGRAMME AND EXHIBITION GUIDE

ELECTRONIC POSTERS

> Phase I/II study of weekly cisplatin plus paclitaxel and radiotherapy for

primary cervical cancer

L. Zhu (China), W. Jiang, S. Tian, A. Qu, H. Wang, X. Li, A. Liao,

Y. Jiang, J. Wang

EP-1325

> The role of PET CT in the IMRT of cervical cancer: the experience of

the Institute of Candiolo

G. Cattari (Italy), S. Squintu, E. Delmastro, E. Garibaldi, S. Bresciani,

P. Scapoli, S. Cauda, C. Bracco, T. Varetto, P. Gabriele

EP-1326

> Clinical outcomes of dose escalation using simultaneous integrated

boost in cervical cancer

R. Verges Capdevila (Spain), A. Varo, M. Mañas, A. Giraldo, J. Giralt

EP-1327

> Phase I study of weekly PTX/DDP, and postoperative radiotherapy for

early cervical cancer in Chinese

L. Zhu (China), W. Jiang, S. Tian, A. Qu, H. Wang, X. Li, J. Wang

EP-1328

> Vaginal & pelvic recurrences of endometrial carcinoma with BT HDR

alone or in combination with EBRT

S. Gribaudo (Italy), U. Monetti, A. Mussano, S. La Sala, E. Madon,

V. Richetto, A. Sardo, A. Rossi, M. Tessa, F. Moretto, A. Ruggieri,

E. Delmastro, G. Cattari, - Katsaros, P. Gabriele, A. Urgesi

EP-1329

> Single center experience with definitive radiotherapy for vaginal cancer

H. Westerveld (The Netherlands), J.J. Den Haan, E.C.M. Rodenburg,

J. Wiersma, G.G. Kenter, B.R. Pieters, L.J.A. Stalpers

EP-1330

> Cancer of uterine cervix: PET-CT, IMRT and HDR.

M. Garcia-Aranda, X. Chen (Spain), A. Montero, J. Valero, R. Alonso,

D. Zucca, R. Ciervide, M. Lopez, B. Alvarez, S. Payano, E. Sanchez,

O. Hernando, C. Rubio

EP-1331

> Clinical results of nimotuzumab plus DDP and concurrent radiotherapy

for primary cervix cancer

L. Zhu (China), S. Tian, A. Qu, H. Wang, X. Li, Y. Jiang, H. Sun,

L. Lin, J. Wang

EP-1332

Electronic Poster

CLINICAL TRACK: PROSTATE

> PSA kinetics after hypofractionated stereotactic body radiotherapy for

localised prostate cancer

H. Kim (Republic of Korea), J.H. Phark, W.C. Kim

EP-1333